Page last updated: 2024-12-05

1,2-naphthoquinone-4-sulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2-Naphthoquinone-4-sulfonate (NQ4S) is a synthetic compound that has been studied for its potential biological activity. It is a quinone derivative that can act as an electron acceptor and has been shown to exhibit antioxidant, anti-inflammatory, and anticancer properties. The compound has been shown to inhibit the proliferation of cancer cells in vitro and in vivo. It is thought to exert its anticancer effects by inducing apoptosis, inhibiting angiogenesis, and reducing oxidative stress. NQ4S has also been shown to protect against neurodegenerative diseases by reducing oxidative stress and inflammation in the brain. Its mechanism of action is not fully understood but is thought to involve redox cycling, which generates reactive oxygen species (ROS) and can lead to cell death. NQ4S is also being investigated for its potential use in the treatment of other diseases, such as diabetes and cardiovascular disease. The synthesis of NQ4S involves the reaction of 1,2-naphthoquinone with sulfuric acid. The reaction is typically carried out at elevated temperatures and in the presence of a catalyst. NQ4S is a relatively stable compound that can be stored for extended periods of time. It is commonly used in research settings to study its biological activity. The importance of 1,2-naphthoquinone-4-sulfonate lies in its potential to serve as a lead compound for the development of new drugs for the treatment of various diseases. Due to its multifaceted biological activities, it is a promising candidate for the development of therapeutic agents with novel mechanisms of action.'
```

1,2-naphthoquinone-4-sulfonic acid: a nonpermeable electron acceptor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,2-naphthoquinone-4-sulfonic acid : An arenesulfonic acid that is 1,2-naphthoquinone substituted at position 4 with a sulfonic acid group. Used principally as a reagent in colorimetric determinations. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10637
CHEMBL ID1205174
CHEBI ID137378
SCHEMBL ID366178
MeSH IDM0058597

Synonyms (26)

Synonym
CHEMBL1205174
3,4-dioxonaphthalene-1-sulfonic acid
3,4-dihydro-3,4-dioxo-1-naphthalene sulfonic acid
1,2-naphthoquinone-4-sulfonic acid
3,4-dioxo-3,4-dihydronaphthalene-1-sulfonic acid
STK329522
3,4-dihydro-3,4-dioxo-1-naphthalenesulfonic acid
2066-93-5
CHEBI:137378
beta-naphthoquinone-4-sulfonic acid
1,2-naphthoquinone-4-sulphonic acid
3,4-dihydro-3,4-dioxonaphthalene-1-sulphonic acid
AKOS001593411
1,2-naphthoquinone-4-sulfonate
ai3-52480
einecs 218-184-8
1-naphthalenesulfonic acid, 3,4-dihydro-3,4-dioxo-
o-naphthoquinone-4-sulfonic acid
.beta.-naphthoquinone-4-sulfonate
.beta.-naphthoquinone-4-sulfonic acid
folin's reagent
DTXSID7062162
SCHEMBL366178
Q27285675
1-naphthalenesulfonicacid,3,4-dihydro-3,4-dioxo-
PD147988

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" This color-developing reaction was successfully employed in the development of simple and rapid spectrophotometric method for determination of FXM in its pharmaceutical dosage forms."( Spectrophotometric study for the reaction between fluvoxamine and 1,2-naphthoquinone-4-sulphonate: Kinetic, mechanism and use for determination of fluvoxamine in its dosage forms.
Abdine, HH; Al-Rayes, LI; Amer, SM; Darwish, IA, 2009
)
0.35
" The methods were validated in terms of accuracy and precision and were successfully applied to the determination of MOX in its pharmaceutical dosage form."( New spectrophotometric methods for the determination of moxifloxacin in pharmaceutical formulations.
Aboul-Enein, HY; Ebraheem, SA; Elbashir, AA; Elwagee, AH, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
colorimetric reagentA reagent used in the determination of the concentration of a coloured chemical element or chemical compound in solution.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
arenesulfonic acidOrganic derivatives of sulfonic acid in which the sulfo group is linked directly to carbon of an aryl group.
naphthalenoneAny naphthalene that is carrying at least one oxo substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID498535Inhibition of beta lactamase CTX-M assessed as hydrolysis of beta lactam by spectrometry analysis2009Nature chemical biology, May, Volume: 5, Issue:5
Molecular docking and ligand specificity in fragment-based inhibitor discovery.
AID498536Inhibition of beta lactamase AmpC assessed as hydrolysis of beta lactam by spectrometry analysis2009Nature chemical biology, May, Volume: 5, Issue:5
Molecular docking and ligand specificity in fragment-based inhibitor discovery.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (20.83)18.7374
1990's9 (18.75)18.2507
2000's18 (37.50)29.6817
2010's9 (18.75)24.3611
2020's2 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.26 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index31.15 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other47 (97.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]